Literature DB >> 8396265

Characterization of a hepatoma mRNA transcribed from a third promoter of a 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-encoding gene and controlled by ets oncogene-related products.

V J Dupriez1, M I Darville, I V Antoine, A Gegonne, J Ghysdael, G G Rousseau.   

Abstract

6-Phosphofructo-2-kinase (EC 2.7.1.105)/fructose-2,6-bis-phosphatase (EC 3.1.3.46) catalyzes the synthesis and degradation of fructose 2,6-bisphosphate, a ubiquitous stimulator of glycolysis. The liver (L-type) and muscle (M-type) mRNAs for this bifunctional enzyme arise from distinct promoters of the same gene. We have now characterized in rat hepatoma FTO2B cells another mRNA, which is transcribed from a third promoter of that gene. This F-type mRNA is present in fetal rat liver and muscle, in rat placenta, and in several established rat cell lines. The F promoter contains no TATA box but contains several binding sites for Sp1 and for members of the ets oncogene family. Transfection of FTO2B cells with constructs containing the intact or mutagenized F promoter showed that its activity depends mainly on one of these sites. This site bound a heteromeric FTO2B cell protein indistinguishable from the ets-related GA binding protein alpha/ankyrin-repeats GA binding protein beta transcription factor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396265      PMCID: PMC47321          DOI: 10.1073/pnas.90.17.8224

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Hormonal control of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene expression in rat hepatoma cells.

Authors:  M E Cifuentes; C Espinet; A J Lange; S J Pilkis; Y Hod
Journal:  J Biol Chem       Date:  1991-01-25       Impact factor: 5.157

2.  Identification of regulatory sequences and protein-binding sites in the liver-type promoter of a gene encoding 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.

Authors:  F P Lemaigre; S M Durviaux; G G Rousseau
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

3.  The Warburg hypothesis fifty years later.

Authors:  S Weinhouse
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976

4.  Characterization of distinct mRNAs coding for putative isozymes of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.

Authors:  K M Crepin; M I Darville; L Hue; G G Rousseau
Journal:  Eur J Biochem       Date:  1989-08-01

5.  5' flanking sequence and structure of a gene encoding rat 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.

Authors:  M I Darville; K M Crepin; L Hue; G G Rousseau
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

6.  Structural features of the acetyl-CoA carboxylase gene: mechanisms for the generation of mRNAs with 5' end heterogeneity.

Authors:  X C Luo; K Park; F Lopez-Casillas; K H Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

7.  Developmental expression of Sp1 in the mouse.

Authors:  J D Saffer; S P Jackson; M B Annarella
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

8.  Sequence-specific DNA binding of the proto-oncoprotein ets-1 defines a transcriptional activator sequence within the long terminal repeat of the Moloney murine sarcoma virus.

Authors:  C V Gunther; J A Nye; R S Bryner; B J Graves
Journal:  Genes Dev       Date:  1990-04       Impact factor: 11.361

9.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

10.  Identification of a novel lymphoid specific octamer binding protein (OTF-2B) by proteolytic clipping bandshift assay (PCBA).

Authors:  E Schreiber; P Matthias; M M Müller; W Schaffner
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

View more
  14 in total

Review 1.  6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis.

Authors:  Mark H Rider; Luc Bertrand; Didier Vertommen; Paul A Michels; Guy G Rousseau; Louis Hue
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

2.  Human alpha-galactosidase A: high plasma activity expressed by the -30G-->A allele.

Authors:  T F Fitzmaurice; R J Desnick; D F Bishop
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

3.  E2F-dependent mitogenic stimulation of the splicing of transcripts from an S phase-regulated gene.

Authors:  M I Darville; G G Rousseau
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

4.  Hepatocyte growth factor and transforming growth factor beta regulate 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene expression in rat hepatocyte primary cultures.

Authors:  M Joaquin; J L Rosa; C Salvadó; S López; T Nakamura; R Bartrons; J Gil; A Tauler
Journal:  Biochem J       Date:  1996-02-15       Impact factor: 3.857

5.  Binding of the Ets factor GA-binding protein to an upstream site in the factor IX promoter is a critical event in transactivation.

Authors:  L M Boccia; D Lillicrap; K Newcombe; C R Mueller
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

6.  Evaluation of quantitative variation in gene expression.

Authors:  E Spanakis; D Brouty-Boyé
Journal:  Nucleic Acids Res       Date:  1994-03-11       Impact factor: 16.971

Review 7.  Transcriptional control of genes that regulate glycolysis and gluconeogenesis in adult liver.

Authors:  F P Lemaigre; G G Rousseau
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

8.  Cloning, sequencing and expression of rat liver 3-phosphoglycerate dehydrogenase.

Authors:  Y Achouri; M H Rider; E V Schaftingen; M Robbi
Journal:  Biochem J       Date:  1997-04-15       Impact factor: 3.857

9.  Cell-type specificity of inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside. Lack of effect in rabbit cardiomyocytes and human erythrocytes, and inhibition in FTO-2B rat hepatoma cells.

Authors:  F Javaux; M F Vincent; D R Wagner; G van den Berghe
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

10.  Hepatocyte nuclear factor 6, a transcription factor that contains a novel type of homeodomain and a single cut domain.

Authors:  F P Lemaigre; S M Durviaux; O Truong; V J Lannoy; J J Hsuan; G G Rousseau
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.